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ABSTRACT 
RNA remodeling proteins, including RNA helicases and chaperones, act to remodel RNA 
structures and/or protein-RNA interactions, and are required for all processes involving RNAs. 
Although many viruses encode RNA helicases and chaperones, their in vitro activities and their roles 
in infected cells largely remain elusive. Noroviruses are a diverse group of positive-stranded RNA 
viruses in the family Caliciviridae, and constitute a significant and potentially fatal threat to human 
health. Here we report that protein NS3 encoded by human norovirus has both ATP-dependent RNA 
helicase activity that unwinds RNA helices and ATP-independent RNA chaperoning activity that can 
remodel structured RNAs and facilitate strand-annealing. Moreover, NS3 can facilitate viral RNA 
synthesis in vitro by noroviral polymerase. NS3 may therefore play an important role in norovirus 
RNA replication. Lastly, we demonstrate that the RNA remodeling activity of NS3 is inhibited by 
guanidine hydrochloride, an FDA-approved compound and, more importantly, that it reduces the 
replication of norovirus replicon in cultured human cells. Altogether, these findings are the first to 
demonstrate the presence of RNA remodeling activities encoded by Caliciviridae, and highlight the 
functional significance of NS3 in noroviral life cycle.  
 
IMPORTANCE 
Noroviruses are a diverse group of positive-stranded RNA viruses, which annually cause 
hundreds of millions of human infections and over 200,000 deaths worldwide. For RNA viruses, 
cellular or virus-encoded RNA helicases and/or chaperones have long been considered to play 
pivotal roles in viral life cycles. However, neither RNA helicase nor chaperoning activity has been 
demonstrated to associate with any norovirus-encoded proteins, and it is also unknown whether 
norovirus replication requires the participation of any viral or cellular RNA helicases/chaperones. We 
found that a norovirus protein NS3 not only has ATP-dependent helicase activity, but also acts as an 
ATP-independent RNA chaperone. And NS3 can facilitate in vitro viral RNA synthesis, suggesting 
the important role of NS3 in norovirus replication. Moreover, NS3 activities can be inhibited by an 
FDA-approved compound, which also suppresses norovirus replicon replication in human cells, 
raising the possibility that NS3 could be a target for anti-noroviral drug development. 
 
INTRODUCTION 
Noroviruses are a genetically diverse group of non-enveloped, positive-stranded RNA viruses 
belonging to genus Norovirus of the family Caliciviridae. They are further segregated into seven 
genogroups (GI-GVII), three of which cause diseases exclusively in humans (GI, GII, and GIV) (14, 
56, 64). Human noroviruses (HuNoVs) are now considered the leading cause of viral gastroenteritis 
in humans across the globe. HuNoV infections are estimated to cause 684 million of cases of 
diarrheal disease, 1.1 million hospitalizations and 212 000 deaths worldwide, with an economic 
burden of ~60 billion dollars per year [8, 9]. They are highly contagious, infecting people of all ages, 
with higher incidence in young children and low-income settings [8, 9]. Although HuNoV infections 
are usually acute and self-limiting with low mortality, they often cause chronic or life-threatening 
infections and symptoms in immunocompromised patients and the elderly (23). As a result of their 
high infectivity, stability and resistance to common sanitizers, HuNoV has also been classified as 
Category B biodefense agents (23, 30). However, despite its substantial burden and potential threat, 
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there is still no vaccines or antiviral drugs available to prevent or treat norovirus infection (2, 24, 25).  
The noroviral genomic RNA is 7.4-7.7 kb in length and typically organized into three open 
reading frames (ORF1-3) (24). Exceptionally, the GV murine norovirus (MNV) has an additional 
ORF (ORF4) encoded within ORF2 (40, 54). The 5´ proximal ORF1 encodes a large polyprotein that 
is cleaved by a norovirus-encoded protease (NS6Pro) into at least six mature nonstructural proteins, 
while the 3´ proximal region of noroviral genomic RNA is transcribed into a subgenomic RNA that 
contains ORF2 and ORF3 that encode the major and minor structural proteins VP1 and VP2, 
respectively (Fig. 1A). Although these viruses have been extensively studied for decades, our 
understanding about the mechanisms of the nonstructural proteins involved in noroviral replication is 
very limited, particularly in comparison to other positive-stranded RNA viruses such as 
picornaviruses and flaviviruses.  
For many RNA viruses, the viral RNA (vRNA) contains multiple cis-acting elements that play 
pivotal roles in vRNA replication, translation and encapsidation, during the viral life cycle (1, 18, 39). 
As with cellular RNA molecules, these elements are often highly structured in vRNAs and must be 
folded into the correct tertiary structures to be functional. However, this can be problematic because 
RNAs can be easily trapped in stable but misfolded intermediate states (3, 19). To avoid this, cells 
and viruses encode a variety of RNA remodeling proteins, such as RNA helicases and RNA 
chaperones, which can destabilize RNA-RNA or RNA-DNA duplexes to promote the proper folding 
or re-folding of RNAs (17, 37, 47). In addition, viral or cellular RNA helicases are thought to 
participate the unwinding of viral replicative intermediate double-stranded RNAs (vRI-dsRNAs) 
formed during vRNA replication, thereby allowing recycling of vRNA templates for further rounds 
of vRNA synthesis. RNA helicases have nucleoside triphosphatase (NTPase) activity, using the 
energy of NTP binding and/or hydrolysis to unwind RNA duplexes, and are believed to participate in 
most ATP-dependent rearrangement of structured RNAs (20). RNA chaperones are a heterogeneous 
group of proteins that can destabilize RNA duplexes and promote correct RNA folding in an 
ATP-independent fashion (41). A wide range of RNA viruses, including flavivirus (15), picornavirus 
(59), alphavirus (22), coronavirus (29), reovirus (60), iflavirus (9), and alphatetravirus (57) have 
been found to encode their own RNA helicases and/or RNA chaperones (61).  
Sequence analysis showed that the norovirus NS3 protein, also known as p41, contains signature 
motifs that are conserved in superfamily-3 (SF3) viral helicases such as the human enterovirus 
2CATPase (EV71 2CATPase) (59), simian virus 40 (SV40) large T antigen (LTag) (31), adeno-associated 
virus 2 (AAV2) Rep40 (10, 63), and the human papillomavirus 18 (HPV18) E1 protein (32) (Fig. 1). 
Consistent with this observation, the NS3 protein encoded by Southampton virus (SHV), a GI 
HuNoV, has been shown to have a NTPase activity (45). In addition, norovirus NS3 has been 
recently reported to associate with vRI-dsRNAs in viral replication complex (vRC) and to induce 
vesicular structures (4, 11, 13). However, previous work has yet to demonstrate RNA helicase or 
chaperoning activity associated with NS3 or any other norovirus- or calicivirus-encoded proteins, or 
that the replication of norovirus or calicivirus requires the participation of any viral or host RNA 
remodeling activities. This gap hampers our understanding about the replication mechanisms of this 
large group of medically important human pathogens, as well as the development of anti-noroviral 
drugs that may specifically target viral RNA helicase/chaperoning activities. 
Our previous work on enterovirus 2CATPase revealed that, in vitro, 2CATPase has RNA remodeling 
activity when expressed using a baculovirus-based expression system (59). Here, we show that NS3 
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encoded by Norwalk virus (NV; genotype GI.1 HuNoV), the prototype strain of the genus Norovirus, 
also has NTP-dependent RNA helicase activity. Moreover, we demonstrate that NS3 can also act as 
an RNA chaperone that is able to remodel structured RNAs and facilitate strand annealing 
independently of NTP. We have also found that NS3 can facilitate the in vitro synthesis of vRNA by 
NV NS7/RNA-dependent RNA polymerase (RdRP) on the 3´ antigenomic template, suggesting that 
NS3 plays important role in noroviral RNA replication. Additionally, we have demonstrated that the 
guanidine hydrochloride (GuHCl), which is a U.S. FDA-approved small molecule drug and a 
well-known inhibitor of poliovirus 2CATPase, is able to inhibit the RNA helicase activity of NS3 in a 
dose-dependent manner. More importantly, GuHCl has been further determined to inhibit the 
replication of NV replicon in cultured human cells, which highlights the functional significance of 
NS3 in noroviral life cycle. 
 
RESULTS 
NV NS3 shares similar consensus motifs and structure with other SF3 viral helicases 
A comparison of the amino acid sequence of NV NS3 with members of the SF3 viral helicases, 
including EV71 2CATPase, AAV2 Rep40, SV40 LTag, and HPV18 E1, revealed that NV NS3 contains 
the conserved SF3 helicase A, B, and C motifs (Fig. 1B). 
Since the three-dimensional (3D) structure of noroviral NS3 has not yet been reported, we 
modeled the NV NS3 structure using the ROBETTA server for protein structure prediction and 
analysis (5). The predicted model of the NV NS3 revealed that the C-terminal two thirds consisting 
of amino acids (a.a) at positions 122-363 (i.e. NS3ΔN) is comprised of two structurally independent 
domains; a helicase core (HC; a.a. 122-288) forming a central five-stranded β-sheet sandwiched by α 
helices on both sides, and the C-terminal domain (CTD; a.a. 289-363) comprising of several α 
helices. These domains are linked by flexible loops (Fig. 1C), and interestingly, demonstrates some 
limited similarity with the counterpart region of EV71 2CATPase (59). Moreover, the predicted SF3 
motifs A, B, and C of NV NS3 are nicely overlapped with the conserved SF3 motifs in these other 
SF3 viral helicases (Fig. 1D-F).  
 
NV NS3 contains NTPase activity  
Previous studies by Pfister and Wimmer found that bacterially expressed Southampton virus 
(SHV) NS3 has NTPase activity (45). To confirm whether NV NS3 also has this activity, we 
expressed recombinant Maltose binding protein (MBP)-fusion NV NS3  using a baculovirus 
expression system , and then examined the NTPase activity by incubating MBP-NS3 with different 
NTPs. The hydrolysis of NTP was measured using a sensitive colorimetric assay that determines the 
total amount of released inorganic phosphate. As found for SHV NS3, our data showed that NV NS3 
hydrolyzed all four types of NTPs (Fig. 2A). However, although SHV NS3 was reported to 
hydrolyze UTP less well than ATP (45), NV NS3 exhibited similar efficiency in the hydrolysis of 
these NTPs (Fig. 2A). 
To further characterize the NTPase activity of NV NS3, we assessed the ATPase activity of 
MBP-NS3 under different of ATP and Mg2+ concentrations as well as at different pH, as ATP is the 
major energy source in cells. Our results showed that the amount of hydrolyzed ATP was increased 
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with increasing amounts of ATP (Fig. 2B). In addition, our data indicates that the ATPase activity of 
MBP-NS3 is Mg2+-dependent, since its ATP hydrolyzing activity was undetectable in absence of 
Mg2+. Whilst the ATPase activity of MBP-NS3 was found to be optimal at 2 mM Mg2+ concentration, 
higher levels of Mg2+ inhibited the ATPase activity (Fig. 2C). The optimal pH for MBP-NS3 ATPase 
activity was found to be ~pH 7.6, but broad activity was maintained between pH 6.8 and pH 8.0 (Fig. 
2D). 
We also expressed MBP-fusion NV NS3 using E. coli, and examined its NTPase activity. We 
confirmed that the bacterially expressed MBP-NS3NV can also hydrolyze ATP and other NTPs and 
shows similar biochemical properties with the eukaryotically expressed MBP-NS3NV (data not show). 
Altogether, our data demonstrate that similar to SHV NS3, the NV NS3 has an NTPase activity that 
hydrolyzes all four NTPs and is Mg2+-dependent. 
 
NV NS3 has nucleic acid helix unwinding activity  
To assess the potential helix unwinding activity of NV NS3, we annealed a short hexachloro 
fluorescein (HEX)-labeled RNA and a longer unlabeled RNA to generate a standard RNA helix 
substrate with both 5´- and 3´-single stranded protrusions (Fig. 3A and Table 1). The helix unwinding 
assay was performed by incubating the standard RNA helix substrate with purified MBP-NS3 in the 
standard unwinding reaction and then the substrate was evaluated via gel electrophoresis. As shown 
in Fig. 3A, the HEX-labeled RNA strand was released from the RNA helix substrate in the presence 
of MBP-NS3, whereas the RNA helix substrate remained annealed when MBP alone was added as a 
mock helicase, showing that NV NS3 can unwind the RNA helix. The reactions were performed in 
the presence of ATP and MgCl2. The boiled helix substrate or the addition of MBP-fusion EV71 
2CATPase were used here and in subsequent experiments as relevant controls for helix unwinding 
activity. 
Because some viral RNA helicases have been reported to unwind DNA helices or RNA-DNA 
hybrids (59), we sought to examine if NV NS3 can unwind nucleic acid helices containing DNA. For 
this purpose, we constructed three helix substrates: a DNA duplex (D*/D; Fig. 3B), an RNA-DNA 
hybrid with a longer unlabeled RNA (D*/R; Fig.. 3C) or DNA strand (R*/D; Fig. 3D). Each helix 
substrate was reacted with MBP-NS3 under the same condition as in Fig. 3A, and our results showed 
that NV NS3 can efficiently unwind either of the RNA-DNA hybrids (Fig. 3C and 3D), but unwound 
the DNA duplexes less effectively (Fig. 3B).  
We further evaluated the RNA helix unwinding activity of MBP-NS3 under different conditions. 
We observed that the helix unwinding activity of MBP-NS3 can be promoted by the presence of NTP, 
particularly ATP or GTP (Fig. 4B), indicating that NV NS3 has an RNA helicase activity. Consistent 
with the characterization of NS3 NTPase activity (Fig. 2C and D), the optimized helix unwinding 
activity of MBP-NS3 was found around 2 mM Mg2+ (Fig. 4C) at pH value of around 7.6 (Fig. 4D). 
Collectively, these findings suggest that the NV NS3 has an NTP-dependent nucleic acid helix 
unwinding activity. 
 
NV NS3 directs the RNA helix unwinding from both 5´→3´ and 3´→5´ directions 
The directionality of helix unwinding is a fundamental characteristic of helicases (20). Previous 
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studies of other SF3 viral helicases have revealed that the helicase activity of EV71 2CATPase has a 
3´→5´ directionality, while AAV2 Rep40 and HPV18 E1 unwind helices bidirectionally (10, 32, 59). 
To determine the unwinding directionality of NV NS3, we generated two different RNA helix 
substrates: one containing a 5´ single-stranded protrusion (Fig. 5A), and the other with a 3´ 
single-stranded protrusion (Fig. 5B). Each substrate was subjected to helix unwinding assay in the 
presence of MBP-NS3. Our data showed that RNA helix substrates with either a 5´- or a 
3´-protrusion could be unwound by MBP-NS3 (Fig. 5C). Moreover, the unwinding of either 
substrate by MBP-NS3 can be promoted by the presence of ATP in a dose-dependent manner (Fig. 
5D and E). Based on these observations, we conclude that NV NS3 directs the unwinding of RNA 
helix from both 5´→3´ and 3´→5´ directions in an ATP-dependent manner, similar to AAV2 Rep40, 
another SF3 viral helicase (10, 32, 59). 
 
The conserved SF3 motif A is critical for the helicase activity of NS3 
The sequence analysis of NS3 indicates that NS3 contains consensus motifs that are 
characteristic of SF3 viral helicases (Fig. 1). The motif A has been recognized as a core element of 
the NTP binding and NTPase active site of SF3 helicases (20) and is conserved in different 
noroviruses (Fig. 6A). Previous work by Pfister et al. has shown that the mutation of motif A in SHV 
NS3 almost completely eliminated its ATPase activity (45). Moreover, motif B of SF3 helicases has 
been reported to chelates Mg2+ (20). We wanted to investigate if the conserved SF3 motif A or B is 
important for the helicase activity associated with norovirus NS3. To this end, we generated the 
GK168AA and GK168AA-DD212AA mutants of MBP-fusion NS3 (MBP-NS3GK168AA and 
MBP-NS3GK168AA-DD212AA) and expressed the proteins using the baculovirus expression system. In 
our standard helix unwinding assays we found that both of the GK168AA and GK168AA-DD212AA 
mutations dramatically reduced the helix unwinding activity of NS3 compared to wild-type (Fig. 6B). 
Moreover, the addition of increasing concentrations of ATP had very little effect on helix unwinding 
by MBP-NS3GK168AA (Fig. 6C). These findings determine that the conserved SF3 motifs are critical 
for the helicase activity of NS3. 
 
NV NS3 also possesses an NTP-independent RNA chaperoning activity 
Although we have determined that NV NS3 requires NTP to reach its optimal helix unwinding 
activity (Fig. 4B, 5D, and 5E) and that the conserved SF3 motif A is critical for its helicase activity 
(Fig. 6), we found that a portion of the helical RNA substrate could still be unwound by MBP-NS3 in 
the absence of ATP (Fig. 4B, 5D, and 5E). To confirm these observations and exclude the possible 
interference of trace amounts of NTP in the unwinding assays, we alternatively used AMP-PNP, an 
ATP analog that is non-hydrolysable and able to block NTPase activity. The incorporation of 5 mM 
AMP-PNP, instead of ATP or other NTPs, did not completely abolish the RNA helix unwinding by 
MBP-NS3 (Fig. 7A). Whilst both the RNA helicases and RNA chaperones possess RNA remodeling 
activities, and the fundamental difference between them is that the former activity requires the 
participation of NTP, whereas the latter is NTP-independent (41). These observations therefore 
suggest that NV NS3 also contains an NTP-independent RNA chaperoning activity. 
RNA chaperones are generally thought to destabilize misfolded RNA secondary structures to 
facilitate the re-formation of more stable RNA structures (19). To further characterize the RNA 
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chaperoning activity of NV NS3, we adapted a canonical assay, which evaluates the 
helix-destabilizing and annealing acceleration activities of RNA chaperones (12). In this assay, we 
designed and generated two 42-nt complementary RNA strands, each of which forms a defined 
stem-loop secondary structure; in addition, one strand is 5’-HEX labeled and the other is unlabeled, 
as indicated in Fig. 7B. Equal amounts of the two strands were mixed and incubated in the presence 
or absence of MBP-NS3, and the hybridization of the two strands were then determined using gel 
shift assay. In these reactions, ATP or other NTPs were not supplemented. Our data showed that the 
levels of the annealed hybrids were gradually increased with the increasing amounts of MBP-NS3 
(Fig. 7C). Moreover, although minimal spontaneous hybridization could be observed in the absence 
of MBP-NS3 with prolonged incubation time (Fig. 7D, lanes 3-6), the addition of MBP-NS3 further 
enhanced the hybridization at each time points (Fig. 7D, lanes 7-10). Altogether, our results show 
that NV NS3 can destabilize structured RNAs and facilitate the formation of a more stable RNA 
structure, confirming that NV NS3 is also a NTP-independent RNA chaperone. 
 
NV NS3 promotes noroviral RNA synthesis in vitro 
For positive-stranded RNA viruses, their RdRP-mediated vRNA replications generate viral 
replicative intermediate double-stranded RNAs that could be unwound by RNA helicases in order to 
recycle vRNA templates (28). Virus-encoded RNA chaperones may help rearrange the structured 
RNA elements of vRNA templates, thereby facilitating vRNA synthesis (60). After determining the 
RNA helicase and chaperoning activities of NV NS3, we wanted to evaluate the potential role of 
NS3 in noroviral RNA replication. As illustrated in Fig. 8A, we incubated a recombinantly purified 
MBP-fusion HuNoV NS7/RdRP protein with in vitro transcribed RNA corresponding to the 400 nts 
at the 3´-end of HuNoV antigenomic (-)-vRNA, which is presumably the template for the initiation 
of (+)-vRNA synthesis, in the presence or absence of WT or GK168AA mutant MBP-NS3. The 
reaction was not supplemented with an oligonucleotide RNA primer as norovirus RNA synthesis can 
occur primer-independently, at least in vitro (16). And the newly synthesized RNA was detected by 
Northern blots using the probe specific for (+)-vRNA. Here, we observed that the presence of WT 
MBP-NS3 promoted the NS7/RdRP-mediated production of (+)-vRNA strands from the (-)-vRNA 
templates, and that the promoting effect of NS3 could be further enhanced with increasing the 
reaction time (Fig. 8B and 8C). On the other hand, the motif A mutation mostly eliminated the 
promoting effect of MBP-NS3 on in vitro RNA synthesis (Fig. 8D and 8E). 
 
GuHCl inhibits the NTPase and RNA helix unwinding activities of NV NS3 
Previous studies have reported that the NTPase and RNA helicase activities of enterovirus 
2CATPase can be inhibited by GuHCl (6, 34, 35, 44, 46, 59), which also inhibits replication of vRNA 
of a number of enteroviruses (38, 53). Given the similarity between the consensus motifs in 
enterovirus 2CATPase and norovirus NS3, we wanted to examine whether NV NS3 could also be a 
target for guanidine inhibition. NTPase assays showed that GuHCl inhibited the ATPase activity of 
NV NS3 in a dose-dependent manner (Fig. 9A). This result is in contrast with the previous 
observation by Pfister and Wimmer who demonstrated that even in the presence of up to 10 mM 
GuHCl, the ATPase activity of SHV NS3 was not inhibited (45). This contrasting results might be 
due to the different expression strategies (eukaryotic vs. prokaryotic) or the inherent biochemical 
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properties of two NS3 proteins, which were also shown to have different hydrolysis preferences for 
UTP (Fig. 2A) and different responses to Mg2+ concentrations higher than 2 mM (Fig. 2C). 
To examine if GuHCl could also inhibit the helix unwinding by NV NS3, the helix unwinding 
reactions were performed in the presence of NS3 and increasing concentrations of GuHCl. Our 
results showed that the presence of GuHCl inhibited the helix unwinding by NS3 in a 
dose-dependent manner (Fig. 9B and C). Intriguingly, we examined the effect of GuHCl on the RNA 
chaperoning activity of NV NS3 using the RNA strand hybridization assay. Our data showed that the 
addition of GuHCl at different concentrations had no obvious effect on NS3 RNA chaperoning 
activity (Fig. 9D). 
It is important to note that the helicase activity and ATPase activity show similar sensitivities to 
GuHCl, and the inhibitory effects due to GuHCl on helicase and ATPase activities of NV NS3 are 
moderate, but similar to the effects observed in EV71 2CATPase (59). Nevertheless, these data 
demonstrate that GuHCl is an inhibitor of the key biochemical activities of NV NS3. 
 
GuHCl inhibits NV replication in cultured human cells 
Whilst we have shown that GuHCl can inhibit the NTPase and helix unwinding activities of NV 
NS3, we sought to determine whether GuHCl treatment can inhibit HuNoV replication in cells. To 
this end, the effect of GuHCl on HuNoV replication was evaluated by using the NV replicon system 
in cultured human gastric tumor (HGT-1) cells. The levels of NV RNA in the presence of GuHCl at 
different concentrations were determined by real-time quantitative reverse transcription-PCR 
(qRT-PCR), and the expression levels of NV proteins were determined by western blotting of NV 
NS3. 2´-C-methylcytidine (2CMC), a nucleoside analog that has been reported to inhibit HuNoV 
replication (49, 50), was used as the positive control. As shown in Fig. 9E, the presence of 1.125 mM 
GuHCl significantly reduced the level of NV RNA to around 50% of that under mock treatment, 
while increasing the GuHCl concentration to 3.25 mM only moderately enhanced the inhibitory 
effect of GuHCl to NV RNA replication. As expected, 2CMC showed a strong inhibitory effect on 
NV RNA replication (Fig. 9E). We also showed that the presence of 1.125 or 3.25 mM GuHCl did 
not affect the viability of HGT-1 cells, as found for 2CMC treated cells, excluding the possibility that 
the inhibitory effect of GuHCl on NV RNA replication was due to inducing cell death (Fig. 9F). 
Hence, GuHCl can inhibit the replication of NV replicon at 1.125 mM in cultured human cells 
without apparent cytotoxicity. 
 
DISCUSSION 
During the life cycle of RNA viruses, cellular or virus-encoded RNA helicases or chaperones are 
believed to facilitate correct folding or unfolding of RNA structures or to separate vRI-dsRNAs for 
more rounds of vRNA replication (3, 19, 59). Here we report for the first time that NV-encoded NS3 
has both NTP-dependent RNA helicase and NTP-independent RNA chaperoning activities that can 
unwind RNA helices, and destabilize and remodel structured RNA molecules. Moreover, we have 
found that NS3 can stimulates NS7/RdRP-mediated noroviral RNA synthesis in vitro, suggesting that 
NS3 plays an important role in noroviral RNA replication. Our work has also shown that GuHCl, an 
FDA-approved small molecule drug, can inhibit the RNA helicase activity of NS3 in vitro, and more 
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importantly, that this small molecule has some inhibitory activity against replication of a HuNoV 
replicon in cultured human cells. 
The RNA remodeling activities of viral proteins are generally believed to play important roles in 
viral life cycles (65). For instance, during vRNA replication of RNA viruses, vRI-dsRNAs must be 
efficiently unwound, thereby releasing nascently synthesized progeny vRNAs from vRNA templates. 
Moreover, viral genomic and antigenomic RNAs contain multiple cis-acting elements, highly 
structured RNA regions that usually play pivotal roles in the replication, translation, and 
encapsidation of vRNAs (1, 36). Sometimes, a specific RNA structure required for one vRNA 
function, like translation or encapsidation, may need disruption and refolding to facilitate another 
vRNA function, like vRNA replication, and vice versa. For example, genomic RNAs or mRNAs of 
some RNA viruses, including norovirus (33, 39, 62), flavivirus (18), hantavirus (48), and reovirus 
(55), can undergo circularization, resulting in the base-pairing of vRNA 5´- and 3´-ends to form 
panhandle-like structures that may facilitate vRNA translation, encapsidation, or RdRP recruitment 
to 3´-end of vRNAs (8, 36). However, for initiation of RNA replication, these cyclized vRNA 
structures need to be disrupted to make the 3´-end of vRNAs accessible by RdRPs; an example of 
this type of activity is the chaperoning effect of cypovirus VP5 on cyclized cypoviral mRNAs (60). 
Viral RNA remodeling proteins may also dynamically facilitate proper folding and unfolding of 
different vRNA structures, thereby allowing vRNAs to switch among distinct functionalities. 
For noroviruses, it has been found that their vRNAs contain multiple cis-acting elements and 
RNA secondary structures, which are important for noroviral replication (33, 36, 39, 62). With that in 
mind it is intriguing that we have observed ability of NS3 to enhance NS7/RdRP-mediated noroviral 
RNA synthesis in vitro, particularly since noroviral NS3 has recently been found to associate with 
vRI-dsRNAs in vRC on intracellular membranes (4, 11, 13). These findings indicate the critical roles 
of NS3 in noroviral RNA replication. However, owing to technical limitations, the RNA remodeling 
activities of viral proteins have been mainly studied in vitro, and it is difficult to imagine how the 
regulation of the structures and functions of vRNAs by viral RNA helicases/chaperones can be 
investigated in detail in virus-infected cells. Future advances in techniques may overcome these 
barriers and help understand the mechanism(s) of how the RNA helicase/chaperoning activities of 
NS3 remodel vRNAs at different stages of noroviral life cycle. 
Interestingly, we found that the guanidine salt, GuHCl, inhibits both the ATPase and RNA helix 
unwinding activities of NV NS3 in a dose-dependent manner (Fig. 9), similar to the effects of the 
same compound on enterovirus 2CATPase (44, 59). Although previous work found that the ATPase 
activity of SHV NS3 was not inhibited by GuHCl (45), our data show that NV NS3 has some 
difference with SHV NS3 in terms of ATPase activity. For example, while SHV NS3 has been found 
to hydrolyze UTP much less well than ATP (30), NV NS3 exhibited similar hydrolysis efficiency to 
both ATP and UTP (Fig. 2A). Moreover, when the concentration of Mg2+ is higher than 2 mM, the 
ATPase activity of NV NS3 was inhibited in a dose-dependent manner (Fig. 2C), while that of SHV 
NS3 was moderately enhanced (30). It is possible that the difference between NV NS3 and SHV NS3 
in ATPase activity is due to the different (eukaryotic vs. prokaryotic) expression strategies. 
Virus-encoded RNA remodeling proteins, particularly helicases, have long been considered as 
valuable targets for antiviral compounds, because they are well conserved within or even across virus 
families (26). In particular, enterovirus 2CATPase, another SF3 viral RNA helicase, has been found to 
be inhibited by ~1 mM GuHCl, as is enterovirus replication (6, 34, 35, 46, 59). Using a NV replicon 
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as model, our studies demonstrate that ~1 mM GuHCl can significantly inhibit the replication of 
HuNoV in cultured human cells with negligible cell toxicity (Fig. 9). Similarly, GuHCl can inhibit 
the replication of poliovirus at the same concentration (59). Guanidines are ubiquitously present in 
nature, and are categorized as organic superbases with highly basic nature and notable stability, that 
can function as mediators of specific non-covalent binding in various catalytic processes (51, 52). 
Due to their physicochemical characteristics, guanidine molecules probably bind stably to the 
surfaces of viral RNA remodeling proteins, such as enterovirus 2CATPase and HuNoV NS3, and may 
therefore alter their conformations, electrostatic states, and/or protein-protein/RNA interactions, 
thereby inhibiting their RNA remodeling activities. In accordance with this idea, high concentrations 
of Mg2+ (> 2mM) have been found to inhibit the helix unwinding by either NV NS3 (Fig. 2C) or 
EV71 2CATPase (59). GuHCl is a U.S. FDA-approved small compound drug that has been used to 
treat the symptoms of muscle weakness and fatigability associated with Eaton-Lambert syndrome  
(http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=00154
6) (42, 43). Moreover, guanidine derivatives have attracted widespread interest for developing drugs 
against various diseases, and some of them have been found to be potential antivirals against 
hepatitis C virus (HCV), human immunodeficiency virus (HIV), and flaviviruses (15, 51, 52). It is 
unlikely that GuHCl can be directly used as an antiviral drug against HuNoV infection due to the 
high concentration needed for inhibition of NS3 and NV replication. However, given the presence of 
multiple derivative forms of guanidine, the syntheses and screening of various guanidine derivatives 
and guanidine-containing compounds may help in the quest for small molecules that have better 
inhibitory effects on HuNoV NS3 and HuNoV replication. 
In conclusion, this study provides the first demonstration of the RNA helicase and chaperoning 
activities associated with a norovirus- or calicivirus-encoded protein, and reveals that NS3 may have 
a direct function (in concert with the NS7/RdRP) in norovirus RNA replication. Moreover, it also 
provides evidence that GuHCl is an inhibitor of not only the in vitro RNA remodeling activities of 
NS3 but also the replication of HuNoV in human cells. Altogether, these findings highlight the 
functional significance of NS3 in noroviral life cycle, and shed new light on the understanding of 
norovirus replication.  
 
MATERIALS AND METHODS 
Construction of recombinant baculoviruses, and expression and purification of recombinant 
proteins 
The generation of pFastBac HTB-MBP has been described previously (9). The cDNA of NV 
NS3 (GenBank Accession No. KF039736) was synthesized by Tian Yi Hui Yuan Biotech Co. (Wuhan, 
China), and cloned into the vector pFastBac HTB-MBP. Site-directed mutagenesis was conducted as 
previously described (9). The resulting plasmids were subjected to Bac-to-Bac baculovirus system to 
produce recombinant proteins. The primers used for NS3 plasmid construction: 
forward-GAATTCATGGGCCCCGAGGACCTTGCCAGGGATCTCGTG and 
reverse-GTCGACCTACTGGAGTTGGAACTCATCCTGTCTCTCCAT; the primers for the 
GK168AA and GK168AA-DD212AA of NS3 are: forward-TGTGGGCCCCC 
TGGTATAGCTGCTACCAAG and reverse-GTTCTGCTGCCTTGGTAGCAGCTAT ACCAG; 
forward-GCTGTGGGCTGCTTATGGAATGACAAAGAT and reverse-TG 
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TATCTTTGTCATTCCATAAGCAGCCCAC. 
The expression and purification of recombinant MBP alone and MBP-fusion proteins were 
conducted using standard procedures as previously described (9, 60). All purified proteins were 
quantified by BCA Protein Assay Kit (CWBIO, China) and stored at -80℃ in aliquots. Proteins were 
separated on 10% SDS-PAGE and visualized by Coomassie blue. 
 
Structural modeling and structural alignment analyses 
The 3D structure of NV NS3 was modeled by submitting its amino acid sequence to the 
HMMSTR/Rosetta server [from Robetta, University of Washington (http://robetta.bakerlab.org/)]. 
Five models were obtained, and the best one was chosen as a template based on its score, and 
assessed by submitting it to the SWISS-MODEL Server [from Swiss Institute of Bioinformatics and 
the Biozentrum, University of Basel, Switzerland (http://siwssmodel.expasy.org)]. The Figure of the 
modeled NS3ΔN and the structural alignments with SV40 LTag (PDB ID code 4GDF), HPV18 E1 
(PDB ID code 1TUE), and AAV2 Rep40 (PDB ID code 1U0J) were generated from coordinate files 
using PyMOL version 1.1 (DeLano Scientific LLC, Southern San Francisco, CA).   
 
NTPase assay 
NTPase activities were determined via measuring the released inorganic phosphate during NTP 
hydrolysis using a direct colorimetric assay according to our standard procedures as previously 
described (9). The concentrations of released inorganic phosphate were determined by matching the 
A620 in a known inorganic phosphate curve. All of the results given with this quantitative assay 
were averages of three independently repeated experiments. 
 
Preparation of oligonucleotide helix substrates 
The nucleic acid helix substrates were prepared according to our standard procedures as 
previous described (59). In brief, RNA, DNA or RNA-DNA hybrid helix substrates were prepared by 
annealing two complementary nucleic acid strands, of which one strand was labeled at 5´-end with 
HEX, while the other was unlabeled. The two strands were mixed at a proper ratio in a 10 μL 
reaction mixture containing 25mM HEPES-KOH (pH 8.0) and 25mM NaCl. And the mixture was 
then heated to 95℃ for 5 min and gradually cooled to 25℃ to produce helical duplexes. All 
HEX-labeled DNA and RNA strands were purchased from Takara (Dalian, China), unlabeled DNA 
strands were synthesized by Invitrogen, and unlabeled RNA strands were in vitro transcribed using 
T7 RNA polymerase (Promega, Madison, WI). The in vitro transcribed RNA strands were purified 
by Poly-Gel RNA Extraction Kit (Omega bio-tek, Guangzhou, China) according to the 
manufacturer’s instructions. The standard RNA helix substrate with both 5´ and 3´ protrusion was 
annealed using RNA1 and RNA2, the DNA helix substrate was annealed using DNA2 and DNA3, 
the RNA*-DNA hybrids was annealed using RNA1 and DNA1, the DNA*-RNA hybrids was 
annealed using DNA1 and RNA3, the 3´ protruded RNA helix was annealed using RNA1 and RNA4, 
and the 5´ protruded RNA helix was annealed using RNA1 and RNA5. All oligonucleotides used in 
this study are listed in Table 1. 
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Table 1. List of oligonucleotides. 
Oligonuleotide Sequence(5’-3’) 
RNA1 *CAUUAUCGGAUAGUGGAACCUAGCUUCGACUAUCGGAUAAUC 
RNA2 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUA
AUGAAAUAA 
RNA3 UGUAGUGCUGCCAUGGUGUGGUGGUGGUGGUUGUGGUGGAGCUAC
GAAC 
RNA4 GAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUAAUGAAA
UAA 
RNA5 AAUAAAGAUUAUCCGAUAGUCGAAGCUAGGUUCCACUAUCCGAUA
AUG 
DNA1 AATAAAGATTATCCGATAGTCGAAGCTAGGTTCCACTATCCGATAATGA
AATAA 
DNA2 *CACCACAACCACCACCACCACACCATGG 
DNA3 TGTAGTGCTGCCATGGTGTGGTGGTGGTGGTTGTGGTGGAGCTACGA
AC 
Probe GUGAAUGAAGAUGGCGUCUAACGGCGCUUCCGCUGCCGCUGUUGC
CAACAGCAACAACGACAUCGCAAAAUCUUCAAGUGACGGUGUGUU
UUCUAACAUGGCUGUCACUUUUAAGCGGGCCCUCGGGGCG 
CGGCCUAAAC 
*indicate HEX labeled strand. 
 
Helix unwinding and RNA strand hybridization assays 
Helix unwinding assay was performed according to our standard procedures as previously 
described (60). The reaction mixtures were electrophoresed on 15% native-PAGE gels and then 
scanned with a Typhoon 9500 imager (GE Healthcare, Piscataway, NJ).  
The RNA hybridization assay was carried out according to our standard procedures as 
previously described (60). In brief, the indicated amount of protein, 0.2 pmol HEX-labeled 
stem-loop-structured RNA strand, and 0.2 pmol unlabeled stem-loop-structured RNA strand were 
added to reaction buffer and incubated for 1 h or the indicated time. The sequences of the 
stem-loop-structured RNA strands are given in Fig. 7B. The reaction products were resolved on 15% 
native-PAGE gels, followed by scanning by Typhoon 9500 imager (GE Healthcare, Piscataway, NJ). 
 
In vitro RdRP assays 
The vRNA template was in vitro transcribed by T7 RNA polymerase as described above. The 
(-)-vRNA template contains 1-400 nts of 3´-end HuNoV (-)-RNA, which is complementary to 5´-end 
Li et al. (2017) – Authors’ Accepted manuscript (doi: 10.1128/JVI.01606-17) 13 
13 
 
400 nts of HuNoV (+)-RNA. The transcribed product was purified by Poly-Gel RNA Extraction Kit 
(Omega bio-tek, Guangzhou, China) according to the manufacturer’s instruction. The cDNA of 
HuNoV NS7/RdRP (GenBank Accession No. KR904238) was amplified by PCR from full-length 
GII.4-Sydney HuNoV cDNA, which was generously provided by Dr. Linqing Zhao (Capital Institute 
of Pediatrics, Beijing, China), and cloned into the vector the vector pMAl-c2X-MBP (primers: 
forward-GGATCCATGGGAGGAAACACTGTCATATG TGCCACCCAG and 
reverse-GTCGACTCACTCGACGCCATCTTCATTCACAAA ACTGGG). The recombinant 
MBP-fusion NS7/RdRP was purified as described above. The RdRP assay was performed as 
previously described with minor modification. In brief, indicated amounts of MBP-NS3 were 
included in 10 μl reactions containing 50mM HEPES-KOH (pH7.5), 12.5mM KCl, 5mM MgCl2, 
5mM DTT, 20U RNasin (Promega), and 5mM NTPs. MBP-NS3 was included in the reaction mix 
with or without 10 pmol NS7/RdRP at 30℃ for the indicated time. After that, the reaction was 
terminated by 2×loading buffer (20% 10×MOPS running buffer, 10% glycerol, 50% formamide, 20% 
formaldehyde and 0.05% bromophenol blue), and then denatured at 65℃ for 10min. The samples 
were electrophoresed on 1.5% agarose-formaldehyde denaturing gels, and transferred onto N+ nylon 
membranes (Roche). The RdRP products were detected via Northern blots that were performed 
according to our standard procedures (58). The probe for Northern blots was listed in Table 1. 
 
Assessment of GuHCl treatment in HuNoV-replicon harboring cells 
A baby hamster kidney cell line harbouring the NV replicon, provided by Dr. Kim Green 
(National Institutes of Health, Bethesda, MD), was used as a source of viral VPg-linked RNA (7). 
Total RNA was isolated from the BHK-NV replicon containing cell line and transfected into HGT-1 
(27). The transfected cells were placed under selection using 1mg/ml of G418 and clonal populations 
were generated by limiting dilution. The levels of viral RNA determined by qRT-PCR as described 
and a single clone selected for future use, referred to as HGT-NV.  
To examine the effect of GuHCl on NV replication, HGT-NV cells were seeded in 96-well plate 
at 1,000 cells per well without G418. HGT-NV cells were immediately incubated with media 
containing various levels of GuHCl or 2CMC as a control. Cells were incubated at 37°C in 5% CO2 
for 3 days. The effect of GuHCl treatment on HuNoV replicon RNA was then evaluated by qRT-PCR 
as described (21) and western blot using rabbit polyclonal antisera to norovirus NS3. In addition, the 
effect of GuHCl on cell viability was determined using CellTiter-Blue (Promega) according to the 
manufacturer’s instructions. 
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FIGURE LEGENDS 
Fig. 1. Norovirus NS3 is similar with other virus-encoded SF3 helicases in consensus motifs and 
protein structures. (A) The genomic RNA of norovirus is depicted, which contains three ORFs (1, 2, 
and 3). The 5’ proximal ORF1 encodes a polyprotein that is subsequently self-cleaved into six 
nonstructural proteins (NS1/2, NS3, NS4, NS5/VPg, NS6Pro, and NS7/RdRP) by viral protease 
NS6Pro. The ORF2 and ORF3 encode structural proteins VP1 and VP2, respectively. (B) Sequence 
alignments of the helicase core domains of NV NS3 and other SF3 viral helicases, including EV71 
2CATPase, SV40 LTag, HPV18 E1, and AAV2 Rep40. The SF3 consensus motifs A, B, and C were 
indicated. (C) The structure of NV NS3 without its N-terminal domain (NS3ΔN) was predicted by 
the HMMSTR/Rosetta server. NS3ΔN containing the middle helicase core (HC) domain and the 
C-terminal domain (CTD) is shown in green. The SF3 motifs A, B, and C are indicated and 
highlighted in red. (D-F) Structural alignments of NV NS3ΔN (green) and SV40 LTag, HPV18E1, or 
AAV2 Rep40 (cyan). The N-terminal domain of E2 binding to HPV18 E1 is shown in brown. The 
SF3 motifs A, B, and C of these viral helicases are highlighted in blue.  
 
Fig. 2. NV NS3 has NTPase activity. (A) MBP-NS3 was reacted with the indicated NTP. The 
NTPase activity was measured as nanomoles of released inorganic phosphate. (B-D) The NTPase 
activity of MBP-NS3 was determined at the indicated concentrations of ATP (B), at the indicated 
concentrations of Mg2+ (C), or at the indicated pH (D). For (B and C), the MBP alone was used as 
the negative control. For (A-D), error bars represent standard deviation (SD) values from three 
separate experiments. 
 
Fig. 3. NV NS3 has nucleic acid helix unwinding activity. (A) The standard RNA/RNA helix 
(R*/R substrate) is illustrated in the upper panel. 0.1 pmol R*/R substrate was reacted with 20 pmol 
each indicated protein. Non-boiled reaction mixture (lane 1) and the reaction mixture with MBP 
alone (lane 3) were used as negative controls, boiled reaction mixture (lane 2) and the reaction 
mixture with purified MBP-fusion EV71 2CATPase (lane 5) were used as positive controls. (B-D) 
DNA/DNA helix (D*/D substrate), DNA/RNA hybrid helix (D*/R), and RNA/DNA hybrid helix 
(R*/D) are illustrated in each upper panel. 0.1 pmol of each indicated substrate was reacted with 20 
pmol each indicted protein. For (B-D), lane 1, non-boiled reaction mixture; lane 2, boiled reaction 
mixture; lane 3, reaction mixture with purified MBP-fusion NS3; lane 4, reaction mixture with 
purified MBP-fusion EV71 2CATPase. The helix unwinding was detected via gel electrophoresis and 
scanning on a Typhoon 9500 imager. Asterisks indicate the HEX-labeled strands.  
 
Fig. 4. Biochemical characterization of RNA helix unwinding activity of NV NS3. (A) 
Illustration of the standard RNA helix (R*/R) substrate. (B-D) 0.1 pmol R*/R substrate was reacted 
with 20 pmol MBP-NS3 in the absence or presence of individual NTP (B), increasing concentrations 
of Mg2+ (C), or different pH values (D) as indicated. Non-boiled (lane 1) or boiled (lane 2) reaction 
mixture was used as negative or positive control. Asterisks indicate the HEX-labeled strands. The 
helix unwinding activity was detected via gel electrophoresis and scanning on a Typhoon 9500 
imager. 
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Fig. 5. NV NS3 unwinds RNA helix in a bidirectional manner. (A and B) Schematic illustration of 
the RNA helix substrate with the 5’ single-stranded protrusion (A) or 3’ single-stranded protrusion 
(B). Asterisks indicate the HEX-labeled strands. (C) MBP-NS3 (20 pmol) was incubated with 5’ 
single-stranded protruded (lane 3) or 3’ single-stranded protruded (lane 6) RNA helix substrate (0.1 
pmol). Non-boiled (lanes 1 and 4) or boiled reaction mixtures (lanes 2 and 5) were used as negative 
or positive controls. (D and E) MBP-NS3 (20 pmol) was reacted with 5’-protruded (D) or 
3’-protruded RNA helix substrate (E) in the presence of indicated concentrations of ATP. The helix 
unwinding was detected as described in Fig. 3. 
 
Fig. 6. The SF3 motif A is critical for the helicase activity of NV NS3. (A) Amino acids sequence 
alignment of NV NS3, SHV NS3, and MNV NS3. The SF3 consensus motifs A, B, and C were 
indicated. (B) The standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 pmol 
wild-type (WT) (lane 4), GK168AA (lane 5), or GK168AA-DD212AA (lane 6) MBP-NS3. 
Non-boiled reaction mixture (lane 1) and the reaction mixture with MBP alone addition (lane 3) were 
used as negative controls; the boiled reaction mixture (lane 2) was used as positive control. (C) The 
standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 pmol GK168AA mutant 
MBP-NS3 in the presence of indicated concentrations of ATP. For (B and C), asterisks indicate the 
HEX-labeled strands. 
 
Fig. 7. NV NS3 has RNA chaperoning activity to destabilize structured RNA strands and 
promote annealing. (A) The standard RNA helix (R*/R) substrate (0.1 pmol) was reacted with 20 
pmol MBP-NS3 in the absence or presence of 5 mM ATP or ATP analog (AMP-PNP) as indicated. 
Lane 1, non-boiled reaction mixture; lane 2,  boiled reaction mixture; lane 3, the reaction mixture 
with MBP-NS3 in the absence of ATP; lanes 4-5, the reaction mixture with MBP-NS3 in the 
presence of AMP-PNP or ATP. (B) Schematic illustrations of the stem-loop structures of the two 
complementary 42-nt RNA strands. Asterisk indicates the HEX-labeled strand. (C) The two strands 
were 1:1 mixed (0.1 pmol each) and reacted with indicated amount of MBP-NS3. (D) The 
hybridization assay as in (C) was conducted in the absence (lanes 3-6) or presence (lanes 7-10) of 20 
pmol MBP-NS3 for indicated reaction times. For (C and D), the pre-annealed (lane 1) or boiled (lane 
2) strands were used as positive or negative control, respectively. The hybridized and free strands are 
indicated. 
 
Fig. 8. NV NS3 facilitates noroviral RNA synthesis in vitro. (A) Schematic illustration of the 
experimental procedures. (B and D) The in vitro transcribed NV 3’-end 1-400 nts of (-)-vRNA 
template was incubated with 10 pmol recombinant NS7/RdRP and NTP mix in the absence or 
presence of 10 pmol MBP-NS3 (B) or MBP-NS3GK168AA (D) at 30 °C for 30, 60 or 90 min as 
indicated. The reaction products were detected by Northern blots. (C and E) The synthesized 
(+)-RNA products in (B and D) were quantified via Bio-Rad Quantity One software. The relative 
RNA production was determined by comparing the level of RNA products in presence of MBP-NS3 
at each indicated time point with that in the absence of NS3 at 30 min (lane 2). The error bars 
represent SD values from three separate experiments. 
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Fig. 9. GuHCl inhibits the biochemical activities of NV NS3. (A) The NTPase activity of 
MBP-NS3 was measured as nanomoles of released inorganic phosphate in the presence of indicated 
concentrations (0-10 mM) of GuHCl. MBP alone was used as the negative control. (B) The standard 
RNA helix (R*/R) substrate is illustrated in the upper panel. 0.1 pmol R*/R substrate was reacted 
with 20 pmol MBP-NS3 in the presence of indicated concentrations (0-10 mM) of GuHCl. Native 
(lane 1) or boiled (lane 2) reaction mixture was used as negative or positive control, respectively. The 
helix unwinding was detected via gel electrophoresis and scanning on a Typhoon 9500 imager. 
Asterisk indicates the HEX-labeled strand. (C) The unwinding activities under different GuHCl 
concentrations were plotted as a percentage of the released RNA from the total RNA helix substrate 
(Y-axis) at each indicated GuHCl concentration (X-axis) via Bio-Rad Quantity One software. The 
error bars represent standard deviation values from three separate experiments. (D) The two strands 
in Fig. 7B were 1:1 mixed (0.1 pmol each) and reacted with 10 pmol MBP-NS3 for 30 min in 
presence of different concentrations of GuHCl in the absence of NTP. The hybridization of the two 
strand was detected via gel electrophoresis and scanning on a Typhoon 9500 imager. The 
pre-annealed (lane 1) or boiled (lane 2) reaction mixture was used as positive or negative control, 
respectively. The hybridized and free strands are indicated. (E) The effect of GuHCl or 2-CMC on 
Norwalk virus RNA levels was determined by examining the impact on NV replicon RNA levels in 
HGT-NV cells following 3 days of treatment. HGT-NV cells were treated with the indicated levels 
of either GuHCl or 2-CMC and the levels of viral RNA calculated as a percentage of mock-treated 
control. (F) HGT-NV cells were treated as in (D) and the number of viable cells were determined. 
The cell viability was calculated as a percentage of mock-treated control. The error bars represent SD 
(n=3). Statistical significance was determined using an unpaired t-test. The experiment was repeated 
at least two independent times, with one representative data set presented. 









